(IUS) RAFI Strategic US - Overview
Etf: Equity, Large-Cap, Quality, U.S., Weighted
Dividends
| Dividend Yield | 1.60% |
| Yield on Cost 5y | 2.76% |
| Yield CAGR 5y | 9.35% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 10.7% |
| Relative Tail Risk | 2.99% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.92 |
| Alpha | 5.78 |
| Character TTM | |
|---|---|
| Beta | 0.805 |
| Beta Downside | 0.846 |
| Drawdowns 3y | |
|---|---|
| Max DD | 15.61% |
| CAGR/Max DD | 1.18 |
Description: IUS RAFI Strategic US December 26, 2025
The Invesco RAFI Strategic US ETF (NASDAQ:IUS) seeks to replicate the RAFI US Large Value Index by fully investing at least 80 % of its assets in the index’s constituent equities, matching each security’s weight in the benchmark. This “full replication” approach aims to deliver performance that closely tracks large-cap U.S. companies characterized by higher quality and larger business scales.
Key metrics (as of the latest filing) include an expense ratio of 0.35 % and assets under management of roughly $1.2 billion. The top holdings are typically dominated by sectors such as industrials, consumer staples, and financials, which tend to benefit from a stable macro-environment and modest interest-rate volatility. Recent data show a dividend yield near 2.8 % and a price-to-book ratio around 1.4×, both of which align with traditional value-style benchmarks.
For a deeper, data-driven look at IUS’s valuation profile, consider reviewing the analytics available on ValueRay.
What is the price of IUS shares?
Over the past week, the price has changed by +1.84%, over one month by +3.67%, over three months by +9.42% and over the past year by +19.45%.
Is IUS a buy, sell or hold?
What are the forecasts/targets for the IUS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 71.8 | 18.7% |
IUS Fundamental Data Overview February 03, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 718.3m USD (718.3m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 718.3m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 718.3m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.88% (E(718.3m)/V(718.3m) * Re(8.88%) + (debt-free company))
Discount Rate = 8.88% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)